Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7347995 Compositions and methods for achieving immune suppression

Patent 7347995 was granted and assigned to Beth Israel Deaconess Medical Center on March, 2008 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Beth Israel Deaconess Medical Center

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

73479950

Patent Inventor Names

Terry B. Strom0

Sylvie Ferrari-Lacraz0

Wlodzimierz Maslinski0

Xin Xiao Zheng0

Yon Su Kim0

Date of Patent

March 25, 2008

Patent Application Number

108534660

Date Filed

May 25, 2004

Patent Citations Received

‌

US Patent 11708392 Peptide conjugates

‌

US Patent 11834519 Compositions and methods for modulating γ-c-cytokine activity

‌

US Patent 12104178 DHFR tunable protein regulation

Patent Primary Examiner

‌

Elizabeth C. Kemmerer

Patent abstract

Disclosed herein are therapeutic compositions containing agents that modulate the immune response in a patient.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7347995 Compositions and methods for achieving immune suppression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API